Prevention of Severe Vestibular Hypofunction after Systemic Gentamicin
Sofía Ferreira-Cendón(Universidad de Salamanca), Ángel Batuecas Caletrío(Universidad de Salamanca), María Sánchez Ledesma(Complejo Hospitalario de Salamanca), Hortensia Sánchez Gómez(Universidad de Salamanca), María José Fernández-Nava(Universidad de Salamanca), Santiago Santa Cruz Ruíz(Universidad de Salamanca), Rosana Villaoslada-Fuente(Universidad de Salamanca), Ramón Martínez-Carranza(Universidad de Salamanca)
Cited by 4
Related Papers
Crimean-Congo Hemorrhagic Fever, Spain, 2013–2021
|Emerging infectious diseases|2023|81
Predicting Success and Long-Term Outcomes of Percutaneous Mitral Valvuloplasty: A Multifactorial Score
|The American Journal of Medicine|2009|52
Identification of serum endoglin as a novel prognostic marker after acute myocardial infarction
|Journal of Cellular and Molecular Medicine|2008|51
Association between -T786C NOS3 polymorphism and resistant hypertension: a prospective cohort study
|BMC Cardiovascular Disorders|2009|34
Impact of Pre- and Postprocedural Mitral Regurgitation on Outcomes After Percutaneous Mitral Valvuloplasty for Mitral Stenosis
|The American Journal of Cardiology|2009|33